- Home
- AKAN vs GCTK Comparison
AKAN vs GCTK Comparison
Compare AKAN & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKAN
- GCTK
- Stock Information
- Founded
- AKAN 2021
- GCTK 2001
- Country
- AKAN Canada
- GCTK United States
- Employees
- AKAN N/A
- GCTK N/A
- Industry
- AKAN Medicinal Chemicals and Botanical Products
- GCTK Medical/Dental Instruments
- Sector
- AKAN Health Care
- GCTK Health Care
- Exchange
- AKAN Nasdaq
- GCTK Nasdaq
- Market Cap
- AKAN 2.9M
- GCTK 3.3M
- IPO Year
- AKAN 2022
- GCTK N/A
- Fundamental
- Price
- AKAN $2.42
- GCTK $7.37
- Analyst Decision
- AKAN
- GCTK
- Analyst Count
- AKAN 0
- GCTK 0
- Target Price
- AKAN N/A
- GCTK N/A
- AVG Volume (30 Days)
- AKAN 1.8M
- GCTK 3.7M
- Earning Date
- AKAN 10-29-2025
- GCTK 11-13-2025
- Dividend Yield
- AKAN N/A
- GCTK N/A
- EPS Growth
- AKAN N/A
- GCTK N/A
- EPS
- AKAN N/A
- GCTK N/A
- Revenue
- AKAN $836,664.00
- GCTK N/A
- Revenue This Year
- AKAN N/A
- GCTK N/A
- Revenue Next Year
- AKAN N/A
- GCTK N/A
- P/E Ratio
- AKAN N/A
- GCTK N/A
- Revenue Growth
- AKAN 183.67
- GCTK N/A
- 52 Week Low
- AKAN $2.30
- GCTK $4.22
- 52 Week High
- AKAN $9.29
- GCTK $2,928.00
- Technical
- Relative Strength Index (RSI)
- AKAN 40.42
- GCTK 57.63
- Support Level
- AKAN $2.85
- GCTK $6.18
- Resistance Level
- AKAN $9.29
- GCTK $7.70
- Average True Range (ATR)
- AKAN 0.85
- GCTK 0.55
- MACD
- AKAN -0.23
- GCTK 0.07
- Stochastic Oscillator
- AKAN 3.38
- GCTK 82.84
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.